Scientific article
English

NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action

Published in

British journal of pharmacology, vol. 164, no. 2b, p. 507-520

Publication date

2011

Abstract

Celastrol is one of several bioactive compounds extracted from the medicinal plant Tripterygium wilfordii. Celastrol is used to treat inflammatory conditions, and shows benefits in models of neurodegenerative disease, cancer and arthritis, although its mechanism of action is incompletely understood.

Keywords

  • Animals
  • CHO Cells
  • Cell Line
  • Cell Line, Transformed
  • Cricetinae
  • Cytosol/drug effects/metabolism
  • HEK293 Cells
  • Humans
  • Hydrogen Peroxide/metabolism
  • NADPH Oxidase/antagonists & inhibitors/metabolism
  • Neutrophils/drug effects/metabolism
  • Onium Compounds/pharmacology
  • Oxidoreductases/metabolism
  • Oxygen/metabolism
  • Protein Binding/drug effects
  • Protein Isoforms
  • Protein Transport/drug effects
  • Reactive Oxygen Species/antagonists & inhibitors/metabolism
  • Superoxides/metabolism
  • Triterpenes/pharmacology
  • Src Homology Domains/drug effects

Citation (ISO format)

JAQUET, Vincent et al. NADPH oxidase (NOX) isoforms are inhibited by celastrol with a dual mode of action. In: British journal of pharmacology, 2011, vol. 164, n° 2b, p. 507–520. doi: 10.1111/j.1476-5381.2011.01439.x

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0007-1188
760views
0downloads

Technical informations

Creation

08/11/2012 15:08:00

First validation

08/11/2012 15:08:00

Update

08/01/2025 10:32:21

Status update

08/01/2025 10:32:21

Last indexation

08/01/2025 10:34:34
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated